PMC:7597510 / 11261-11415 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T97","span":{"begin":40,"end":43},"obj":"Disease"},{"id":"T98","span":{"begin":60,"end":68},"obj":"Disease"},{"id":"T99","span":{"begin":71,"end":80},"obj":"Disease"}],"attributes":[{"id":"A97","pred":"mondo_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A98","pred":"mondo_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A99","pred":"mondo_id","subj":"T99","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":" supports the notion that patients with GBS associated with SARS-CoV-2 infection tend to test negative for antiganglioside antibodies. In addition to care"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T94","span":{"begin":89,"end":93},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":" supports the notion that patients with GBS associated with SARS-CoV-2 infection tend to test negative for antiganglioside antibodies. In addition to care"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"237","span":{"begin":26,"end":34},"obj":"Species"},{"id":"238","span":{"begin":60,"end":80},"obj":"Disease"}],"attributes":[{"id":"A237","pred":"tao:has_database_id","subj":"237","obj":"Tax:9606"},{"id":"A238","pred":"tao:has_database_id","subj":"238","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" supports the notion that patients with GBS associated with SARS-CoV-2 infection tend to test negative for antiganglioside antibodies. In addition to care"}